Palo Alto Investors LP Ptc Therapeutics, Inc. Transaction History
Palo Alto Investors LP
- $442 Million
- Q2 2025
A detailed history of Palo Alto Investors LP transactions in Ptc Therapeutics, Inc. stock. As of the latest transaction made, Palo Alto Investors LP holds 406,469 shares of PTCT stock, worth $18.4 Million. This represents 4.49% of its overall portfolio holdings.
Number of Shares
406,469
Previous 404,196
0.56%
Holding current value
$18.4 Million
Previous $20.6 Million
3.62%
% of portfolio
4.49%
Previous 4.11%
Shares
4 transactions
Others Institutions Holding PTCT
# of Institutions
308Shares Held
80.1MCall Options Held
255KPut Options Held
151K-
Vanguard Group Inc Valley Forge, PA8.85MShares$401 Million0.01% of portfolio
-
Black Rock Inc. New York, NY7.77MShares$352 Million0.01% of portfolio
-
Rtw Investments, LP New York, NY7.75MShares$351 Million5.81% of portfolio
-
Armistice Capital, LLC New York, NY4.74MShares$214 Million4.05% of portfolio
-
Wellington Management Group LLP Boston, MA4.69MShares$213 Million0.04% of portfolio
About PTC THERAPEUTICS, INC.
- Ticker PTCT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 71,541,000
- Market Cap $3.24B
- Description
- PTC Therapeutics, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of medicines to patients with rare disorders. Its portfolio pipeline includes commercial products and product candidates in various stages of development, including clinical, pre-clinical and research and discovery stages, focuses on...